Pixelgen Technologies 🇸🇪
Series B · $15.5M
Oversubscribed Series B to speed up global expansion and unlock new insights into biology.
About Pixelgen Technologies
Pixelgen Technologies specializes in protein interactomics, utilizing a patented Proximity Network Assay that enables nanoscale spatial analysis of immune cell proteins. This technology supports the development of products aimed at enhancing precision medicine and advancing research in immunology, hematology, and cell therapy.
Pixelgen Technologies is a Sweden-based company founded in 2020, now around 43 people. It has raised $15.5M in disclosed funding.
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Want the latest on Pixelgen Technologies? Our research agent pulls the current
description, latest round and full investor base from public sources (about a minute).
Series B · $15.5M · Aug 2026
- Industrifonden — Evergreen Swedish venture capital fund founded in 1979 and based in Stockholm. · cheques £750k – £3.8M
- Wallenberg Investments (Navigare Ventures) — Wallenberg Investments' Ventures unit was launched in 2021 as Navigare Ventures, a wholly owned Stockholm-based subsidiary of Wallenberg Investments AB.